Global Cell Therapy Raw Materials Market Expected to Reach USD 48.04 Billion by 2034

Dublin, April 02, 2024 (GLOBE NEWSWIRE) -- The "Global Cell Therapy Raw Materials Market Analysis & Forecast to 2024-2034: Market By Product; By End-user; and By Region" report has been added to's offering.

Market Overview

The global cell therapy raw materials market is experiencing exponential growth, primarily led by the drive in addressing chronic diseases through advanced treatment modalities and innovative product introductions. The industry was valued at USD 4.32 billion in 2023 and is projected to burgeon to a market size of USD 48.04 billion by 2034, with an impressive CAGR of 24.48% from 2024-2034.

Technological Advancements Fostering Growth

A prime factor contributing to this market surge is the significant technological progress within the realm of cell therapy, including developments in cell culture media, which accounted for the largest segment of revenue in 2023. This growth illustrates an increased investment from key industry players in optimizing the cell therapy process. Advancements in antibodies are forecasted to witness the fastest growth rate in the market due to their importance in targeted treatments and immune modulation.

Emerging End-User Contributions

Biopharmaceutical and pharmaceutical companies represented the highest revenue contributors among end-users as of 2023, driven by a robust research and development ecosystem and the rising demand for cell-based therapies. Notably, Contract Research Organizations (CROs) and Contract Manufacturing Organizations (CMOs) are anticipated to expand rapidly due to their critical support in cell therapy advancements through specialized service offerings.

Geographic Momentum

The North American market is predicted to maintain the highest share of global revenue throughout the forecast period. This is largely due to the region's conducive regulatory environment, significant investments in novel therapies, and substantial involvement of leading firms in cell therapy innovation. Meanwhile, the Asia Pacific region is expected to experience the most rapid growth rate due to its emerging biotechnological industries and increasing prevalence of chronic and degenerative diseases, coupled with a heightened focus on cell therapy research and development.

Industry Influence and Future Directions

These projections indicate an influential period ahead for the cell therapy raw materials market, with continued advancements and strategic expansions anticipated to steer the industry towards new heights in medical treatment. This growth trajectory suggests a transformative period for cell-based therapeutic approaches globally, offering hope for enhanced patient outcomes and healthcare innovation.

Market Segmentation Insight

The global cell therapy raw materials market is segmented into various product categories including cell culture media, reagents, antibodies, and other raw materials. Additionally, the market analysis distinguishes key end-user categories and provides detailed insights into regional market landscapes, assessing areas like North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa for comprehensive market understanding.

For in-depth market analysis and understanding, experts across the biopharmaceutical and medical research industries are advised to consider the detailed segmentation and comprehensive regional assessments provided in the most recent market reports. These insights are set to play an integral role in shaping future strategies and developments within the rapidly expanding cell therapy raw materials industry.

Key Attributes

Report AttributeDetails
No. of Pages200
Forecast Period2023 - 2034
Estimated Market Value (USD) in 2023$4.32 Billion
Forecasted Market Value (USD) by 2034$48.04 Billion
Compound Annual Growth Rate24.4%
Regions CoveredGlobal

Companies Featured

  • ACROBiosystems
  • Merck KGaA
  • PromoCell GmbH
  • Charles River Laboratories
  • Actylis.
  • Thermo Fisher Scientific Inc.
  • Danaher
  • STEMCELL Technologies.
  • Sartorius Stedim Biotech
  • Grifols S.A.
  • RoosterBio Inc.

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


Global Cell Therapy Raw Materials Market

Contact Data